Evercore ISI upgrades Vertex Pharmaceuticals, Inc. (VRTX) rating to an Outperform
In a filing, Vertex Pharmaceuticals, Inc. revealed its Director Bhatia Sangeeta N. unloaded Company’s shares for reported $0.19 million on
In a filing, Vertex Pharmaceuticals, Inc. revealed its Director Bhatia Sangeeta N. unloaded Company’s shares for reported $0.19 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Vertex Pharmaceuticals,
Vertex Pharmaceuticals, Inc.’s recently made public that its SVP & Chief Accounting Officer Ambrose Kristen unloaded Company’s shares for reported
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Vertex Pharmaceuticals, Inc. revealed its SVP & Chief Accounting Officer Ambrose Kristen unloaded Company’s shares for reported
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Vertex Pharmaceuticals, Inc. revealed its SVP & Chief Accounting Officer Ambrose Kristen unloaded Company’s shares for reported
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Vertex Pharmaceuticals, Inc.’s recent filing unveils that its SVP & Chief Accounting Officer Ambrose Kristen unloaded Company’s shares for reported